12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Kiacta eprodisate regulatory update

Bellus said Japan's Ministry of Health, Labor and Welfare (MHLW) granted Orphan Drug designation for Kiacta eprodisate to treat amyloid A (AA)...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >